prośba o radę

08.10.07, 14:20
Witam serdecznie,
jestem pierwszy raz na forum. Mam pytanie odnośnie wspomagania
leczenia w sposób naturalny np. takim preparatem.

www.allegro.pl/item252220864_immune_power_300_z_ahcc_hit_z_usa_.html

Wiem, ze często pacjenci uzupełniają leczenie różnymi środkami a
lekarze mają raczej sceptyczne podejscie. Dlatego chcę najpierw
skonsultować się tutaj a potem z lekarzem prowadzącym mając juz
jakieś wasze opinie.
    • mazunia1 Re: prośba o radę 08.10.07, 14:38
      to wydawanie pieniędzy w błoto, chorego należy wspomagać, ale są
      specjalne preparaty przepisane przez onkologa oraz odpowiednią dietą.
    • scept89 Re: Ganoderma + shitake 08.10.07, 16:00
      Ganoderma lucidum ((Reishi, Lingzhi)
      en.wikipedia.org/wiki/Reishi#Current_usage
      www.blackwell-synergy.com/doi/abs/10.1111/j.1750-3841.2007.00431.x
      poza tradycyjnymi zaspiewami znachorow o leczeniu 100 chorob i dolegliwosci z
      roznych dzialow medycyny wykazuje dzialanie in vitro na kk neo, zobacz artykul
      ponizej. Problem w tym ze nawet zakladajac iz firma jest OK i nie sprzedaje
      sproszkowanych pieczarek czy borowikow (jak to sprawdzisz?) to i tak naturalne
      odmiany Ganoderma roznia sie drastycznie skladem i dzialaniem. Bez badan
      renomowanego producenta wykazujacych iz dany zbior grzybkow rzeczywiscie dziala
      chocby na kk neo w laboratorium jest to malo sensowne.

      Grzybki shitake mozesz kupic w sklepach spozywczych, choc rozumiem ze zupa
      grzybowa ma mniejsze dzialanie na psychike pacjenta niz "cudowne" kapsulki z
      tymze samym grzybem... Jedzenie shitake nie powinno przynajmniej zaszkodzic w
      normalnych sytuacjach, ale poniewaz substancje zawarte w shitake obnizaja
      zlepianie plytek krwi to zdecydowanie nalezy skonsultowac to z lekarzem
      prowadzacym.

      en.wikipedia.org/wiki/Shitake#Medicinal_use
      Ganoderma lucidum in cancer research
      Leukemia Research
      Volume 30, Issue 7, July 2006, Pages 767-768
      Daniel Sliva
      Ganoderma lucidum, popular medicinal mushroom, has been used as a home remedy in
      traditional Chinese medicine (TCM) in many Asian countries during the past two
      millennia [1]. The regular consumption of G. lucidum in the form of tea or
      mushroom powder was believed to preserve the human vitality and to promote
      longevity [2]. G. lucidum has been also used for the prevention or treatment of
      a variety of diseases including cancer [3]. Western medicine started to accept
      natural product from the TCM and the popularity of herbal therapies for the
      treatment of cancer have been recently increasing in the United States [4].
      Therefore, scientific justification based on the elucidation of mechanisms
      responsible for the biological effects of these natural products could help for
      their validation in alternative or adjuvant cancer therapies. The anticancer
      effects of G. lucidum were associated with triterpenes [5], polysaccharides [6]
      and [7], or immunomodulatory proteins [8], through the mechanisms involving
      inhibition of DNA polymerase [9], inhibition of post-translational modification
      of the Ras oncoprotein [10], or the stimulation of cytokine production [11].
      Moreover, G. lucidum: (i) inhibits proliferation and invasive behavior of breast
      and prostate cancer cells through the down-regulation of expression of cyclin-D1
      and suppression of secretion of urokinase-plasminogen activator (uPA) [12], [13]
      and [14]; (ii) inhibits growth and induces apoptosis of breast and prostate
      cancer cells through the up-regulation of expression of p21 and Bax [15] and
      [16]; (iii) inhibits growth of hepatoma cells through the suppression of protein
      kinase C [17]; (iv) induces apoptosis of colon cancer cells by increasing the
      activity of caspase-3 [18]; (v) suppresses angiogenesis through the inhibition
      of secretion of vascular endothelial growth factor (VEGF) and transforming
      growth factor-β1 (TGF-β1) from prostate cancer cells [19].

      In this issue of Leukemia Research, Müller et al. [20] evaluated the effects of
      G. lucidum on cancer cells of hematologic origin, and they found that G. lucidum
      inhibits proliferation and induces apoptosis in a variety of leukemia, lymphoma,
      and myeloma cells. Moreover, they showed that the inhibition of proliferation of
      acute myoloblastic leukemia HL-60 cells was associated with cell cycle arrest at
      G2/M phase and apoptosis, whereas the inhibition of proliferation and apoptosis
      of lymphoma U937 was mediated by the up-regulation of expression of p21 and p27.
      Therefore, Müller et al. further increased our knowledge about the anticancer
      effects of G. lucidum on hematopoietic cells, and confirmed that G. lucidum
      inhibits distinct signaling pathways in different cancer cells. Finally, they
      used standardized G. lucidum extract containing 0.15% ganoderic acid C2.
      Although triterpenes or triterpenoid fractions from G. lucidum previously
      demonstrated anticancer effects in vitro as well as in vivo, it is uncertain if
      this amount of ganoderic acid could be responsible for the effect of G. lucidum
      on hematopoietic cells. Nevertheless, the standardization of G. lucidum is
      crucial for its characterization since the composition and amount of
      biologically active triterpenes depend on the places of the production,
      cultivation conditions, extraction procedures and the strains of G. lucidum
      [21]. As recently demonstrated, some extracts of G. lucidum markedly inhibited
      intracellular signaling and invasive behavior of cancer cells, whereas other
      extracts did not show any effect [22]. Thus, the standardization of G. lucidum
      is necessary for the acceptance of G. lucidum as a natural product suitable for
      the treatment of cancer.

      The major obstacle for the acceptance of natural products in Western medicine is
      their complexity. However, this complexity can also bring significant
      advantages. For example, certain components in the natural products can reduce
      the cytotoxicity of the whole product, and the interaction between different
      biologically active components can be responsible for their in vivo effects
      [23]. In addition, different compounds can modulate unrelated signaling and
      therefore, can possess synergistic effect [24]. Thus, triterpenes in G. lucidum
      directly suppress growth and invasive behavior of cancer cells, whereas G.
      lucidum polysaccharides stimulate immune system resulting in the production of
      cytokines and activation of anti-cancer activities of immune cells [5] and [25].
      In conclusion, although the data from the recent studies demonstrating the
      effect of G. lucidum on the molecular level are promising, preclinical and
      clinical studies with G. lucidum are necessary for the validation of this
      natural product in the prevention and/or therapy of cancer.
Pełna wersja